Need for Resistance Testing a Factor in Selection of IFN-Free Therapies for Hep C: Hepatologist

Dr Yatsuhashi Hiroshi Yatsuhashi, head of Nagasaki Medical Center’s Clinical Research Center, said that doctors’ choices of interferon (IFN)-free therapies for chronic hepatitis C have been affected by whether or not testing for hepatitis C virus (HCV) drug resistance mutations...read more